Technology | February 03, 2012

FDA Clears St. Jude Medical’s Cool Path Duo, Safire BLU Duo Ablation Catheters

February 3, 2012 – The U.S. Food and Drug Administration (FDA) approved the premarket approval application (PMA) for the St. Jude Medical Therapy Cool Path Duo and Satire BLU Duo ablation catheters and the IBI 1500T-9 VI.6 cardiac ablation generator. The system is indicated for creating endocardial lesions during cardiac ablation procedures (mapping, stimulation and ablation) for the treatment of typical atrial flutter.

The cardiac radiofrequency (RF) ablation catheters are compatible with the irrigation pump and 1500T9-CP RF generator at a maximum of 50 watts.

The Therapy Cool Path Duo is a sterile, single use 7 French catheter that is constructed of thermoplastic elastomer material and four noble metal electrodes. This catheter has a through-lumen connected to open conduits at the 4mm tip electrode for heparinized saline irrigation during the ablation procedure. The tip curvature may be manipulated by the thumb control mechanism located on the handle at the proximal end of the catheter. The catheter manipulation is uni-directional. The catheter distal curve is indicated on the catheter label.

The Safire BLU Duo is a sterile, single use 7 French catheter that is constructed of thermoplastic elastomer material and four noble metal electrodes. This catheter has a through-lumen connected to open conduits at the 4 mm tip electrode for heparinized saline irrigation during the ablation procedure. The tip curvature may be manipulated by the thumb and forefinger control mechanism located on the handle at the proximal end of the catheter. The catheter manipulation is bi-directional. The catheter distal curve is indicated on the catheter label.

The catheters are inserted into a blood vessel, usually though a site in the upper leg or neck. The catheter is manually advanced through the blood vessels until it reaches the correct location inside the heart. The tip of the catheter is moved around by a mechanism on the handle. Inside the heart, electrodes at the tip gather data that pinpoint the location of the faulty tissue in the heart (electrical mapping). Once the site is identified, the device delivers RF energy to destroy the small areas of tissue that blocks the heart's internal electrical signals that cause the typical atrial flutter. The catheters are removed after treatment.

In a clinical study involving 188 patients, The FDA said abnormal rhythms (typical atrial flutter) were corrected in 181 patients (96 percent) for seven days after treatment; and it remained corrected after three months in 174 patients (94.5 percent).

For more information: www.fda.gov

 

Related Content

Medtronic Cryoballoon Improves Quality of Life, Reduces Systems of Persistent Atrial Fibrillation
News | Ablation Systems | August 28, 2018
Medtronic plc announced new findings from the CRYO4PERSISTENT AF clinical trial demonstrating improved quality of life...
Thermedical Announces FDA IDE Approval for Clinical Study of Durablate Catheter
News | Ablation Systems | August 02, 2018
Thermedical announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device...
Boston Scientific to Acquire Cryterion Medical Inc.
News | Ablation Systems | July 13, 2018
Boston Scientific Corp. recently announced a definitive agreement to acquire Cryterion Medical Inc., a privately-held...
Treating AFib With Ablation Reduces Mortality and Stroke
News | Ablation Systems | July 05, 2018
Using catheter-based ablation instead of medications alone reduces the risks of death and stroke in patients with the...
LuxCath Showcases OmniView Light-Guided Ablation Catheter at HRS 2018
News | Ablation Systems | May 22, 2018
LuxCath LLC showcased the next generation of its proprietary OmniView light-guided catheter ablation system at the 2018...
The Kardium Globe combined mapping and ablation catheter. The device has a distal multi-electrode array consisting of 16 ribs with 122 gold-plated electrodes. Ablation can be done with up to 24 electrodes simultaneously.  #HRS2018

The Kardium Globe combined mapping and ablation catheter. The device has a distal multi-electrode array consisting of 16 ribs with 122 gold-plated electrodes. Ablation can be done with up to 24 electrodes simultaneously. 

News | Ablation Systems | May 21, 2018
May 21, 2018 — Complete pulmonary vein isolation (PVI) was achieved in more than 99 percent of patients in a first-in
CardioFocus Announces Successful Live Case Featuring HeartLight X3 System
News | Ablation Systems | May 17, 2018
Medical device manufacturer CardioFocus Inc. announced a successful live case featuring its HeartLight X3 System during...
Imricor MRI-Guided Cardiac Ablation Study Results to Be Presented at HRS 2018
News | Ablation Systems | May 10, 2018
Results from the clinical study to evaluate Imricor’s Vision-MR Ablation Catheter for the treatment of atrial flutter...
Biosense Webster Launches Carto Vizigo Bi-Directional Guidance Sheath
Technology | Ablation Systems | May 08, 2018
Biosense Webster Inc. announced its Carto Vizigo Bi-directional Guiding Sheath is now available in the United States....
Stereotaxis and Acutus Medical Announce Strategic Collaboration
News | Ablation Systems | May 04, 2018
Stereotaxis and Acutus Medical announced a strategic collaboration to integrate the Stereotaxis Niobe Magnetic...
Overlay Init